这是一篇来自已证抗体库的有关
人类 VHL的综述,是根据16篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合VHL 抗体。
VHL 同义词: HRCA1; RCA1; VHL1; pVHL; von Hippel-Lindau disease tumor suppressor; elongin binding protein; protein G7; von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
圣克鲁斯生物技术
小鼠 单克隆(VHL40) | | 圣克鲁斯生物技术 VHL抗体(Santa Cruz, sc-135657)被用于被用于免疫印迹在人类样品上 (图 1d). Am J Transl Res (2017) ncbi |
小鼠 单克隆(VHL40) | | 圣克鲁斯生物技术 VHL抗体(Santa Cruz, sc-135657)被用于被用于免疫印迹在人类样品上 (图 3b). J Cell Biol (2017) ncbi |
小鼠 单克隆(D-7) | | 圣克鲁斯生物技术 VHL抗体(Santa Cruz, D-7)被用于被用于免疫印迹在人类样品上 (图 4). J Cell Sci (2016) ncbi |
小鼠 单克隆(G-7) | | 圣克鲁斯生物技术 VHL抗体(Santa Cruz Biotechnology, SC-17780)被用于被用于免疫印迹在人类样品上. Br J Pharmacol (2015) ncbi |
小鼠 单克隆(D-7) | | 圣克鲁斯生物技术 VHL抗体(Santa Cruz, sc-55506)被用于被用于免疫细胞化学在人类样品上 (图 1). Oncotarget (2015) ncbi |
MyBioSource
兔 多克隆 | | MyBioSource VHL抗体(MyBioSource, MBS125962)被用于被用于免疫印迹基因敲除验证在人类样品上 (图 1). Oncogene (2016) ncbi |
艾博抗(上海)贸易有限公司
兔 多克隆 | | 艾博抗(上海)贸易有限公司 VHL抗体(Abcam, ab28434)被用于被用于免疫印迹在人类样品上浓度为1:1000. PLoS ONE (2013) ncbi |
赛默飞世尔
小鼠 单克隆(Ig33) | | 赛默飞世尔 VHL抗体(Lab Vision, Ig33)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:200. Med Oncol (2014) ncbi |
碧迪BD
小鼠 单克隆(Ig32) | | 碧迪BD VHL抗体(BD Biosciences, 556347)被用于被用于其他在人类样品上 (图 4c). Cancer Cell (2018) ncbi |
小鼠 单克隆(Ig32) | - reverse phase protein lysate microarray; 人类; 图 st6
| 碧迪BD VHL抗体(BD Pharmingen, 556347)被用于被用于reverse phase protein lysate microarray在人类样品上 (图 st6). Cancer Cell (2017) ncbi |
小鼠 单克隆(Ig32) | - reverse phase protein lysate microarray; 人类; 图 3a
| 碧迪BD VHL抗体(BD Pharmingen, 556347)被用于被用于reverse phase protein lysate microarray在人类样品上 (图 3a). Nature (2017) ncbi |
小鼠 单克隆(S2-647) | - 免疫细胞化学; 人类; 图 2
- 免疫印迹; 人类; 图 1
| 碧迪BD VHL抗体(BD Pharmingen, 564183)被用于被用于免疫细胞化学在人类样品上 (图 2) 和 被用于免疫印迹在人类样品上 (图 1). Int J Cancer (2016) ncbi |
小鼠 单克隆(Ig32) | | 碧迪BD VHL抗体(BD Biosciences, 556347)被用于被用于免疫印迹在人类样品上 (图 8). J Biol Chem (2016) ncbi |
小鼠 单克隆(Ig32) | | 碧迪BD VHL抗体(BD, 556347)被用于被用于免疫沉淀在人类样品上 (图 4). Nature (2016) ncbi |
小鼠 单克隆(Ig32) | | 碧迪BD VHL抗体(BD Biosciences, BD556347)被用于被用于免疫组化在小鼠样品上浓度为1:100 (图 9a). Am J Pathol (2015) ncbi |
小鼠 单克隆(Ig32) | | 碧迪BD VHL抗体(BD Bioscience, Ig32)被用于被用于免疫印迹在小鼠样品上浓度为1:500 (图 5,6). Nat Commun (2015) ncbi |
小鼠 单克隆(Ig32) | | 碧迪BD VHL抗体(BD-Bioscience, Ig32)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:50. Med Oncol (2014) ncbi |
Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y,
et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10
pubmed 出版商
Li S, Liu H, Tang S, Li X, Wang X. MicroRNA-150 regulates glycolysis by targeting von Hippel-Lindau in glioma cells. Am J Transl Res. 2017;9:1058-1066
pubmed
Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R,
et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423
pubmed 出版商
Labrousse Arias D, MartÃnez Alonso E, Corral Escariz M, Bienes MartÃnez R, Berridy J, Serrano Oviedo L,
et al. VHL promotes immune response against renal cell carcinoma via NF-κB-dependent regulation of VCAM-1. J Cell Biol. 2017;216:835-847
pubmed 出版商
. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384
pubmed 出版商
German P, Bai S, Liu X, Sun M, Zhou L, Kalra S,
et al. Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function. Oncogene. 2016;35:4973-80
pubmed 出版商
Ruf M, Moch H, Schraml P. PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma. Int J Cancer. 2016;139:396-403
pubmed 出版商
Heir P, Srikumar T, Bikopoulos G, Bunda S, Poon B, Lee J,
et al. Oxygen-dependent Regulation of Erythropoietin Receptor Turnover and Signaling. J Biol Chem. 2016;291:7357-72
pubmed 出版商
Chen K, Zeng J, Xiao H, Huang C, Hu J, Yao W,
et al. Regulation of glucose metabolism by p62/SQSTM1 through HIF1α. J Cell Sci. 2016;129:817-30
pubmed 出版商
Lee S, Frattini V, Bansal M, Castano A, Sherman D, Hutchinson K,
et al. An ID2-dependent mechanism for VHL inactivation in cancer. Nature. 2016;529:172-7
pubmed 出版商
Mangiavini L, Merceron C, Araldi E, Khatri R, Gerard O Riley R, Wilson T,
et al. Fibrosis and hypoxia-inducible factor-1α-dependent tumors of the soft tissue on loss of von Hippel-Lindau in mesenchymal progenitors. Am J Pathol. 2015;185:3090-101
pubmed 出版商
Kim B, Lee J, Choi J, Park D, Song H, Park T,
et al. Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization. Br J Pharmacol. 2015;172:3875-89
pubmed 出版商
Chen K, Yu G, Gumireddy K, Li A, Yao W, Gao L,
et al. ZBRK1, a novel tumor suppressor, activates VHL gene transcription through formation of a complex with VHL and p300 in renal cancer. Oncotarget. 2015;6:6959-76
pubmed
Hsiao H, Hsu T, Liu W, Hsieh W, Chou T, Wu Y,
et al. Deltex1 antagonizes HIF-1α and sustains the stability of regulatory T cells in vivo. Nat Commun. 2015;6:6353
pubmed 出版商
Lessi F, Mazzanti C, Tomei S, Di Cristofano C, Minervini A, Menicagli M,
et al. VHL and HIF-1?: gene variations and prognosis in early-stage clear cell renal cell carcinoma. Med Oncol. 2014;31:840
pubmed 出版商
Gammon L, Biddle A, Heywood H, Johannessen A, Mackenzie I. Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism. PLoS ONE. 2013;8:e62493
pubmed 出版商